Michael Myers

Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland.

Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd. is a private company that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. The company is based in Chantilly, VA. Fuisz Technologies was acquired by Biovail Corp. on November 12, 1999 for $145.48 million.

Innocoll Holdings, Inc. manufactures pharmaceutical products. The company is based in Ashburn, VA.

Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA.

Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA.

Innocoll Pharmaceuticals Ltd. engages in pharmaceutical preparations. The company was founded on June 1, 2005 and is headquartered in Dublin, Ireland.

Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland.